New testing portfolios

We are glad to launch several new testing portfolios – Asper Cardiogenetics, Asper Neurogenetics, and Asper Wellness. Asper Cardiogenetics covers genetic tests related to cardiovascular diseases, including Long QT syndrome, Marfan syndrome, Noonan syndrome, as well as tests for prediction of adverse drug reactions. Asper Neurogenetics includes genetic tests for the diagnostics of diseases with neurologic and metabolic involvement.

Tests for determining disease risks, food intolerance, and athletic performance can be found in Asper Wellness portfolio.

Genetic conditions assembled in new testing menus are detectable mainly by multi-gene panels, but single gene testing and targeted mutation analysis are also available.